The treatment landscape for chronic lymphocytic leukemia has dramatically changed in the past decade.
Charalambos Andreadis, MD, MSCE
Advertisement
Articles by Charalambos Andreadis, MD, MSCE
Advertisement
Latest Updated Articles
CLL14 Trial: Fixed-Duration Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLLPublished: November 14th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
4
What Do Physicians and Patients Think About ADCs as Cancer Treatment?
5
